Results 171 to 180 of about 177,338 (265)
Trends in Meningitis Burden and Projections to 2040: A Secondary Analysis of the Global Burden of Disease Study 2023. [PDF]
Azizmohammad Looha M +4 more
europepmc +1 more source
This study reveals that Alzheimer's disease–linked APP expression in bone‐forming cells drives skull bone marrow remodeling and alters its vascular connections to the brain. These changes disrupt immune cell trafficking, cerebral blood flow, and cognition. Targeting bone marrow macrophages restores brain function, highlighting a previously unrecognized
Lei Xiong +6 more
wiley +1 more source
Differential cytokine signature profiles in neonates, infants, and children with enterovirus meningitis. [PDF]
Chabrolles H +16 more
europepmc +1 more source
Infective Endocarditis Diagnosed by Emergency Physicians Using Cardiac POCUS: A Case Series
ABSTRACT Introduction Emergency physicians (EPs) are acquiring ever‐increasing expertise in cardiac point‐of‐care ultrasound (POCUS). We compiled this case series to demonstrate current practice by EPs diagnosing infective endocarditis (IE) using POCUS.
Jonathan Henry +8 more
wiley +1 more source
Clinical features and risk factors for outcomes of postoperative bacterial meningitis in pediatric neurosurgery: a retrospective study from 2013 to 2023. [PDF]
Han S +7 more
europepmc +1 more source
Beyond the Lungs: A Rare Case of Klebsiella pneumoniae Meningitis. [PDF]
Mashal SM +4 more
europepmc +1 more source
A simple, rapid, and sustainable HPLC‐UV method was developed and validated to quantify meropenem in human plasma across a wide linear range (0.5–100 mg/L). Utilizing an efficient one‐step protein precipitation, this eco‐friendly approach is highly suited for routine clinical therapeutic drug monitoring and research purposes.
Asma Aboelezz +2 more
wiley +1 more source
Disseminated Tuberculosis Presenting As Scrofuloderma and Tuberculous Meningitis With Ischemic Stroke in the Absence of a Pulmonary Disease. [PDF]
Rivera A, Muñoz H, Dunaway TA.
europepmc +1 more source
ABSTRACT Background Tuberculous meningitis (TBM) carries a case fatality rate of up to 50% in resource‐limited settings despite standard anti‐tuberculosis therapy. Adjunctive corticosteroids are widely recommended, yet their effect on mortality and safety across diverse populations remains imprecisely defined.
Ayesha Younas +14 more
wiley +1 more source

